Treatments for ovarian cancer haven't changed much since I was diagnosed over 18 years ago. The protocols have been pretty much the same.
Until now. PARP Inhibitors (Poly(ADP-ribose) polymerase (PARP) inhibitors) are offering real hope to many in our community.
Initially thought to be of benefit only to women who are BRCA-positive, we now know that PARP inhibitors can benefit patients with ovarian cancer regardless of whether they have inherited risk factors.
We've gathered some articles here for you that help tell the story of PARP inhibitors and where this exciting research is leading. While it may not be a CURE for ovarian cancer, PARP inhibitors seem to be a big step forward in progression-free survival for many women.
- Jeanene Smith, Associate Director